Heel Incision Devices Market: Introduction
According to the report, the global heel incision devices market was valued at ~US$ 174 Mn in 2019. The heel incision devices market is projected to expand at a CAGR of ~3% from 2024 to 2030. Blood samples from infants can be obtained from either an indwelling catheter or a heel puncture. Puncturing a newborn’s heel for blood collection is a crucial step in the process of detecting potentially fatal, congenital diseases. Heel incision devices are safe, gentle, and effective to collect blood from babies. Heel incision device provides a precise incision for adequate blood sampling with less re-sticking.
Heel incision devices are available for newborn, preemie, micro-preemie, and toddler. North America dominated the global heel incision devices market in 2019. The trend is anticipated to continue during the forecast period. Mandatory newborn screening under the Newborn Screening Saves Lives Act of 2007 across North America propels the demand for heel incision devices.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79383
Mandatory Newborn Testing Policy Adopted in Several Countries to Drive Heel Incision Devices Market
Premature babies, especially those born very early, often have complicated medical issues. Typically, complications of prematurity vary; however, earlier the baby is born, the higher the risk of complications. Therefore, dozens of new tests are presently available, which can offer insights into the health condition of newborns. High birth rate of preterm babies leads to complications and even to death of babies within one month of birth, which is a global concern, especially in underdeveloped and developing countries of Africa and South Asia. Consequently, several countries, such as the U.S., Australia, Germany, and the U.K., have introduced numerous health policies under which newborn screening is mandatory, which, in turn, propels the heel incision devices market.
Products for Newborns to Dominate Heel Incision Devices Market
In terms of product type, the global heel incision devices market has been classified into micro-preemie, preemie, newborn, and infant. Doctors prefer to screen newborns within the first 1 to 2 days after birth to diagnosis diseases, as it takes that long for abnormal levels to show up in the blood, and this is likely to fuel the segment.
Request for Analysis of COVID-19 Impact on Heel Incision Devices Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=79383
Hospitals & Specialty Clinics to be Highly Attractive End User
In terms of end user, the heel incision devices market has been divided into hospitals & specialty clinics, ambulatory surgical centers, and others. The high preference for hospitals & nursing homes due to availability of all levels of treatment, reimbursement facilities, and rise in awareness about different treatment support provided in hospitals are key factors driving the segment.
North America to Dominate Heel Incision Devices Market
The global heel incision devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global heel incision devices market in 2019, followed by Europe. North America accounted for a major share of the global heel incision devices market in 2019, primarily due to well-established healthcare infrastructure that enables proper diagnosis. Moreover, a rise in awareness about newborn screening in the U.S. drives the demand for heel incision devices.
Buy Heel Incision Devices Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=79383<ype=S
Heel Incision Devices Market: Competition Landscape
The global heel incision devices market is fragmented in terms of number of players. Key players in the global surgical equipment market include BD, Owen Mumford Ltd., Cardinal Health, Smiths Medical, Clinical Innovations, LLC, MediCore, Vitrex Medical A/S, NSP Medicals, and Torvan Medical Inc.
More Trending Reports by Transparency Market Research –
Gonorrhea Therapeutics Market: https://www.biospace.com/article/gonorrhea-therapeutics-market-high-scope-of-advancement-with-curative-approach/
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
